Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Statement regarding share price

hVIVO
Posted on: 10 Apr 18

The Board of hVIVO plc (AIM: HVO) notes the sudden and extreme fall in its share price in recent days and confirms that it knows of no reason for such a fall.

 

The Company announced initial results on 26 March 2018 of a Phase IIb study examining FLU-v as a potential universal vaccine against influenza (flu) which, although only indicating a trend to statistical significance of the primary endpoint, did demonstrate a statistically significant reduction in overt flu symptoms and gives the Board cause for optimism that its investment in FLU-v (through its joint venture Imutex Limited) has potentially significant future value.

 

The Company will announce its audited preliminary results for the year ended 31 December 2017 on 19 April 2018.  Financial results for the year ended 31 December 2017 are expected to be in-line with market expectations, with cash as at 31 December 2017 of £20.3 million (2016: £25.7 million) which is markedly ahead of expectations.

 

 

For further information please contact:

 

hVIVO plc

+44 207 756 1300

Kym Denny (Chief Executive Officer)

 

Graham Yeatman (Chief Financial & Business Officer)

 

 

 

Media Enquiries

+1 919 710 9658

Susan Flood

 

 

 

Numis Securities Limited

+44 207 260 1000

Michael Meade / Freddie Barnfield (Nominated Adviser)

 

James Black / Michael Burke (Corporate Broking)

 

 

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 10/04/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.